Stummvoll G H, Fritsch R D, Meyer B, Hoefler E, Aringer M, Smolen J S, Steiner G
G Steiner, Division of Rheumatology, Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18, A-1090 Vienna, Austria.
Ann Rheum Dis. 2009 Jan;68(1):110-6. doi: 10.1136/ard.2007.082032. Epub 2008 Mar 28.
To address key aspects of anti-histone autoimmunity in systemic lupus erythaematosus (SLE), we performed a detailed characterisation of cellular and humoral autoreactivity to histone H1 and the four core histones H2A, H2B, H3, H4 in patients with SLE and healthy controls.
Peripheral blood mononuclear cells of 41 patients with SLE and 28 healthy controls were exposed to individual histones and proliferation was measured by [(3)H]-thymidine incorporation. H1-reactive T cell clones were obtained by limiting dilution. Cytokines and total IgG in culture supernatants was measured by ELISA, and autoantibodies to histones were determined by ELISA and immunoblotting.
Proliferative responses to H1 were more frequent and more pronounced in cell cultures from patients with SLE (p<0.002), while among the core histones only the response to H2A was increased in patient cultures (p<0.01). All histones elicited a Th1-like cytokine response in patients and controls (high interferon (IFN)gamma and tumour necrosis factor (TNF)alpha, no interleukin (IL)4) with H1 inducing the highest levels of TNFalpha. However, H1 stimulated production of IgG and anti-histone antibodies only in cell cultures derived from patients with SLE. H1-specific T cell clones from patients and controls showed a CD4+CD28+ phenotype and a Th1 cytokine profile. Anti-histone antibodies were detected in 51% of patients with SLE, were primarily directed to H1, H3 and H4, and predominantly of the IgG2 subtype.
Histone H1 constitutes a major B cell and T cell autoantigen in SLE, triggering a proinflammatory Th1 response and driving autoantibody production. This suggests that histone H1 may be of considerable relevance for the pathogenesis of SLE.
为了探讨系统性红斑狼疮(SLE)中抗组蛋白自身免疫的关键方面,我们对SLE患者和健康对照者针对组蛋白H1以及四种核心组蛋白H2A、H2B、H3、H4的细胞和体液自身反应性进行了详细表征。
将41例SLE患者和28例健康对照者的外周血单个核细胞暴露于单个组蛋白,并通过[³H] - 胸腺嘧啶核苷掺入法测量增殖情况。通过有限稀释法获得H1反应性T细胞克隆。用酶联免疫吸附测定(ELISA)法测量培养上清液中的细胞因子和总IgG,并通过ELISA和免疫印迹法测定抗组蛋白自身抗体。
SLE患者细胞培养物中对H1的增殖反应更频繁且更明显(p<0.002),而在核心组蛋白中,仅患者培养物中对H2A的反应增加(p<0.01)。所有组蛋白在患者和对照中均引发类似Th1的细胞因子反应(高干扰素(IFN)γ和肿瘤坏死因子(TNF)α,无白细胞介素(IL)4),其中H1诱导的TNFα水平最高。然而,H1仅在源自SLE患者的细胞培养物中刺激IgG和抗组蛋白抗体的产生。来自患者和对照的H1特异性T细胞克隆显示CD4 + CD28 +表型和Th1细胞因子谱。在51%的SLE患者中检测到抗组蛋白抗体,主要针对H1、H3和H4,且主要为IgG2亚型。
组蛋白H1是SLE中主要的B细胞和T细胞自身抗原,引发促炎性Th1反应并驱动自身抗体产生。这表明组蛋白H1可能与SLE的发病机制密切相关。